Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy-Reference-Cited by-同舟云学术

Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy

Published:2017-01-12 Issue:1 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Yanagita Tadahiko,Murata Yoji,Tanaka Daisuke,Motegi Sei-ichiro,Arai Eri,Daniwijaya Edwin Widyanto,Hazama Daisuke,Washio Ken,Saito Yasuyuki,Kotani Takenori,Ohnishi Hiroshi,Oldenborg Per-Arne,Garcia Noel Verjan,Miyasaka Masayuki,Ishikawa Osamu,Kanai Yae,Komori Takahide,Matozaki Takashi

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference60 articles.

1. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

2. Microenvironmental regulation of tumor progression and metastasis

3. Immune suppressive mechanisms in the tumor microenvironment

4. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

5. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials;Kohrt;J Immunother Cancer,2016

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies;Immunology;2024-08-11

2. The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis;EMBO Molecular Medicine;2024-07-30

3. A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response;Antibody Therapeutics;2024-07

4. Clinical Significance of SIRPα Expression on Tumor-Associated Macrophages in Patients with Lung Squamous Cell Carcinoma;Annals of Surgical Oncology;2024-06-29

5. Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells;iScience;2024-04